Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$7.31 - $11.18 $41,111 - $62,876
-5,624 Reduced 6.8%
77,052 $580,000
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $8,380 - $12,835
884 Added 1.08%
82,676 $837,000
Q3 2022

Nov 18, 2022

SELL
$9.2 - $13.68 $122,047 - $181,478
-13,266 Reduced 13.96%
81,792 $809,000
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $506,660 - $943,345
88,577 Added 1366.72%
95,058 $1.01 Million
Q1 2022

May 16, 2022

BUY
$7.46 - $14.14 $313 - $593
42 Added 0.65%
6,481 $63,000
Q4 2021

Feb 15, 2022

BUY
$12.99 - $17.73 $246 - $336
19 Added 0.3%
6,439 $92,000
Q3 2021

Nov 15, 2021

BUY
$14.85 - $21.34 $95,337 - $137,002
6,420 New
6,420 $129,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.